Cerity Partners’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,050
Closed -$101K 2829
2025
Q2
$101K Buy
+11,050
New +$81.4K ﹤0.01% 2477
2024
Q2
Sell
-15,449
Closed -$428K 2351
2024
Q1
$428K Sell
15,449
-85,941
-85% -$1.91M ﹤0.01% 1671
2023
Q4
$1.95M Buy
101,390
+3,383
+3% +$61.3K 0.01% 781
2023
Q3
$1.58M Sell
98,007
-10,452
-10% -$186K 0.01% 636
2023
Q2
$2.06M Buy
108,459
+92,035
+560% +$1.64M 0.01% 725
2023
Q1
$1.02M Sell
16,424
-4,726
-22% -$84.7K ﹤0.01% 965
2022
Q4
$413K Buy
21,150
+10,082
+91% +$197K ﹤0.01% 1025
2022
Q3
$266K Buy
+11,068
New +$341K ﹤0.01% 947
2018
Q2
Sell
-20,084
Closed -$312K 575
2018
Q1
$312K Buy
20,084
+128
+0.6% +$2.28K 0.02% 423
2017
Q4
$377K Buy
19,956
+40
+0.2% +$887 0.03% 391
2017
Q3
$582K Sell
19,916
-6,541
-25% -$193K 0.04% 297
2017
Q2
$1.08M Buy
26,457
+6,326
+31% +$208K 0.09% 167
2017
Q1
$697K Buy
+20,131
New +$719K 0.06% 224

Other funds holding ACH

Cerity Partners's ACH Position: Q3 2025 in Review

Cerity Partners sold out of Accendra Health (ACH) in Q3 2025, closing a stake of 11,050 shares — an estimated $101K sold.

Cerity Partners first reported a position in ACH in Q1 2017 and held it in 13 quarters. The position peaked at $2.06M in Q2 2023. 202 funds tracked by Wall St. Rank hold ACH as of Q3 2025.

  • Cerity Partners reported no remaining Accendra Health position as of Q3 2025 after selling out during the quarter.
  • Cerity Partners sold 11,050 Accendra Health shares in Q3 2025, an estimated $101K.
  • Cerity Partners first reported a position in Accendra Health in Q1 2017 and held it in 13 quarters.
  • Cerity Partners's Accendra Health position peaked at $2.06M in Q2 2023.
  • 202 funds tracked by Wall St. Rank held Accendra Health as of Q3 2025.

Based on Cerity Partners's 13F filing for Q3 2025, filed 22 Oct 2025.